Chlamydia screening for pregnant women aged 16–25 years attending an antenatal service: a cost-effectiveness study

Abstract

Objective: Determine the cost-effectiveness of screening all pregnant women aged 16–25 years for chlamydia compared with selective screening or no screening. Design: Cost effectiveness based on a decision model. Setting: Antenatal clinics in Australia. Sample: Pregnant women, aged 16–25 years. Methods: Using clinical data from a previous study, and outcomes data from the literature, we modelled the short-term perinatal (12-month time horizon) incremental direct costs and outcomes from a government (as the primary third-party funder) perspective for chlamydia screening. Costs were derived from the Medicare Benefits Schedule, Pharmaceutical Benefits Scheme, and average cost-weights reported fo..